Hangzhou Zhiwei Information & Technology Co., Ltd (Zhiwei) pioneered in applying artificial intelligence to cytopathological diagnosis. The company provides cytopathological artificial intelligence solutions for global customers with state-of-the-art technological innovation. It, headquartered in Hangzhou, established its wholly owned subsidiariesis in Shaoxing, Zhejiang, Hong Kong, and Massachusetts. We have been committed to independent research and development for a long time. As the facility to launch a fully-automatic analysis system of bone marrow cell morphology (Morphogo) firstly in the world, our company has been certificated and registered in China, Japan, Europe, Australia, UK and other countries, with our business extending to more than 30 countries around the world.